Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency

Academic Article


  • An immunodeficient patient with protracted COVID-19 unable to mount a humoral immune response rapidly recovered following transfusion with convalescent plasma. Honjo et al. found that immunotherapy with high-titer neutralizing antibodies was clinically beneficial. However, since neutralizing activity of convalescent plasmas varies widely, units should be tested prior to therapy.
  • Digital Object Identifier (doi)

    Author List

  • Honjo K; Russell RM; Li R; Liu W; Stoltz R; Tabengwa EM; Hua Y; Prichard L; Kornbrust AN; Sterrett S
  • Volume

  • 2
  • Issue

  • 1